GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | decreases expression | EXP | | 6480464 | CTD | Diethylnitrosamine results in decreased expression of AKR7A3 mRNA | PMID:11323195 | increases expression | EXP | | 6480464 | CTD | Diethylnitrosamine results in increased expression of AKR7A3 mRNA | PMID:19638242, PMID:21813463 | multiple interactions | EXP | | 6480464 | CTD | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of AKR7A3 mRNA, [Diethylnitrosamine co-treated with oxfendazole co-treated with isoquercitrin] results in increased expression of AKR7A3 mRNA, [Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of AKR7A3 mRNA, [ethofenprox co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA, [Omeprazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA, [oxfendazole co-treated with Diethylnitrosamine] results in increased expression of AKR7A3 mRNA, Melatonin inhibits the reaction [[Diethylnitrosamine co-treated with oxfendazole] results in increased expression of AKR7A3 mRNA] | PMID:18164116, PMID:18754104, PMID:20033131, PMID:22129741, PMID:22467020, PMID:22687989, PMID:28943392 | |
Go Back to source page | Continue to Ontology report |